Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb;68(2):165-169.
doi: 10.4103/ija.ija_496_23. Epub 2024 Jan 29.

Median effective dose of intranasal dexmedetomidine for satisfactory mask induction in children undergoing examination under anaesthesia for retinoblastoma - A prospective up and down sequential allocation study

Shalini Subramanian  1 , Deepa Shetty  1 , Gagan Dudeja  2 , Priyanka Das  3
Affiliations

Median effective dose of intranasal dexmedetomidine for satisfactory mask induction in children undergoing examination under anaesthesia for retinoblastoma - A prospective up and down sequential allocation study

Shalini Subramanian et al. Indian J Anaesth. 2024 Feb.

Abstract

Background and aims: Inhalational technique is used to induce anaesthesia in children without intravenous access. We aimed to determine the median effective dose (ED50) of intranasal dexmedetomidine to ensure satisfactory mask acceptance during inhalation induction in children with retinoblastoma undergoing examination under anaesthesia.

Methods: A prospective sequential allocation study was conducted in children aged 1-60 months divided into Group A (1-18 months) and Group B (18-60 months). Children were administered dexmedetomidine intranasally as premedication. Sedation was assessed using the modified Observer Assessment of Alertness and Sedation Scale until induction. Successful mask acceptance was defined as a cooperative or asleep child during inhalational induction. The starting dose of dexmedetomidine was 1 µg/kg. The next dose varied by 0.2 µg/kg depending on the outcome of this case. According to the Dixon up-and-down method, the mean of midpoints of the failure-success sequence was calculated to obtain the ED50 values.

Results: The ED50 of intranasal dexmedetomidine for satisfactory mask acceptance was 0.7 µg/kg (95% confidence interval [CI]: 0.54-0.86) in Group A (n = 23) and 0.96 µg/kg (95% CI: 0.83-1.08) in Group B (n = 25) (P = 0.020). The mean (standard deviation) duration of anaesthesia was 33.5 (14.9) minutes in group A versus 23.5 (8.48) minutes in Group B (P = 0.007).

Conclusion: ED50 was lower in children younger than 18 months than in older children. There was no difference in the time to discharge from the post-anaesthesia care unit despite the procedure being longer in smaller children.

Keywords: Children; dexmedetomidine; facemask; inhalation induction; intranasal; mask acceptance; median effective dose; sedation.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Dexmedetomidine dose (a) children aged <18 months, (b) children aged 18–60 months. Solid circle represents satisfactory mask acceptance. An open circle represents failed mask acceptance
See this image and copyright information in PMC

References

    1. Dave NM. Premedication and Induction of Anaesthesia in paediatric patients. Indian J Anaesth. 2019;63:713–20. - PMC - PubMed
    1. Rao R, Honavar SG. Retinoblastoma. Indian J Pediatr. 2017;84:937–44. - PubMed
    1. Fabian ID, Shah V, Kapelushnik N, Naeem Z, Onadim Z, Price EA, et al. Number, frequency and time interval of examinations under anaesthesia in bilateral retinoblastoma. Graefes Arch Clin Exp Ophthalmol. 2020;258:879–86. - PubMed
    1. Yu Q, Liu Y, Sun M, Zhang J, Zhao Y, Liu F, et al. Median effective dose of intranasal dexmedetomidine sedation for transthoracic echocardiography in pediatric patients with noncyanotic congenital heart disease: An up-and-down sequential allocation trial. Pediatr Anesth. 2017;27:1108–14. - PubMed
    1. Gokhan O, Mir Hyder A. Use of intranasal dexmedetomidine as a solo sedative for magnetic resonance imaging of infants. Hosp Pediatr. 2018;141:68–71.